Correlation Between Insurance Australia and Bio Gene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Insurance Australia and Bio Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Insurance Australia and Bio Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Insurance Australia Group and Bio Gene Technology, you can compare the effects of market volatilities on Insurance Australia and Bio Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Insurance Australia with a short position of Bio Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Insurance Australia and Bio Gene.

Diversification Opportunities for Insurance Australia and Bio Gene

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Insurance and Bio is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Insurance Australia Group and Bio Gene Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Gene Technology and Insurance Australia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Insurance Australia Group are associated (or correlated) with Bio Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Gene Technology has no effect on the direction of Insurance Australia i.e., Insurance Australia and Bio Gene go up and down completely randomly.

Pair Corralation between Insurance Australia and Bio Gene

Assuming the 90 days trading horizon Insurance Australia is expected to generate 4.24 times less return on investment than Bio Gene. But when comparing it to its historical volatility, Insurance Australia Group is 13.42 times less risky than Bio Gene. It trades about 0.31 of its potential returns per unit of risk. Bio Gene Technology is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  4.30  in Bio Gene Technology on November 3, 2024 and sell it today you would earn a total of  0.60  from holding Bio Gene Technology or generate 13.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Insurance Australia Group  vs.  Bio Gene Technology

 Performance 
       Timeline  
Insurance Australia 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Insurance Australia Group are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain technical and fundamental indicators, Insurance Australia unveiled solid returns over the last few months and may actually be approaching a breakup point.
Bio Gene Technology 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Bio Gene Technology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Bio Gene may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Insurance Australia and Bio Gene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Insurance Australia and Bio Gene

The main advantage of trading using opposite Insurance Australia and Bio Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Insurance Australia position performs unexpectedly, Bio Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Gene will offset losses from the drop in Bio Gene's long position.
The idea behind Insurance Australia Group and Bio Gene Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum